Sentences with phrase «disclosure purposes under»

In the cases I reviewed here, every official in the justice system failed the test — a governing body of the legal profession that released documents to the police without a warrant, a judge who granted a wiretap authorization with a general warrant to search mobile devices without limitation other than a temporal one and a Crown attorney who released privileged information after presumptively reviewing it for disclosure purposes under the Stinchcombe regime.

Not exact matches

Investigatory material compiled solely for the purpose of determining suitability, eligibility, or qualifications for Federal civilian employment, military service, Federal contracts, or access to classified information, but only to the extent that the disclosure of such material would reveal the identity of a source who furnished information to the Government under an express promise that the identity of the source would be held in confidence.

Under California law, California Residents who have an established business relationship with Startup Grind may choose to opt out of Startup Grind's disclosure of personal information about them to third parties for direct marketing purposes.

CIPSEA is contained in Public Law 107 - 347, Title V. and includes fines and penalties for unauthorized disclosures of information collected under a pledge of confidentiality where the information is designated exclusively for statistical purposes.

NHTSA's CARS.gov website contains a Privacy Act Statement (telling the record subject the authority for seeking the information and whether its disclosure is mandatory or voluntary, the principal purpose for which the information will be used, the routine uses of the information, and the effects of not providing the requested information) relating to NHTSA's collection of PII under the CARS Program.

The following entities under the control of Standard Life Aberdeen plc have been identified for the purposes of this disclosure:

However, codifying these disclosures under the TSR will create a more defined bright line standard for enforcement purposes and will leave little or no doubt as to what obligations debt relief companies have to inform their customers.

Under the California «Shine The Light» law, California residents may opt - out of the disclosure of personal information to third parties for direct marketing purposes (as those concepts are defined in that law) However, we do not currently engage in the type of sharing covered by that law.

[10] See Jurewicz v. U.S. Dept. of Agric., No. 10 - 1683 JEB, 2012 WL 4130515 (D.D.C. Sept. 20, 2012) at * 11 («[T] he purpose and plain language of the Act mandate a strong presumption in favor of disclosure» of a dog breeder's operational information including the quantity of dogs sold and revenue gained, and thus breeder's disclosure was not exempt under Freedom of Information Act).

Should The Hotel Erwin inadvertently acquire personal information or any other data from users under the age of 18, The Hotel Erwin will not knowingly provide this data to any third party for any purpose whatsoever, and any subsequent disclosure would be due to the fact the user under 18 used the Site and submitted personal information without solicitation by or permission from The Hotel Erwin.

Under California law, our users that are California residents may request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

Taylor Wessing refused on three grounds: the documents would not be disclosable under Bahamian law and were protected by privilege under English law; disproportionate effort on their part would be required to inspect the documents; and the purpose of the SAR was to obtain disclosure for the sake of litigation.

It then held, «[t] o the extent that PIPA restricted the Union's collection, use and disclosure of personal information for legitimate labour relations purposes, the Act violates s. 2 (b) of the Charter and can not be justified under s. 1.»

This disclosure or transfer is for specific purposes under an agreement or arrangement between the Government of Canada and the government of a foreign state.

In any case, voluntary disclosure of a violation to rules and regulations under the powers of CVM (identified in an internal review, for instance) is considered for purposes of diminishing penalties or negotiating lower payments in settlement agreements.

(a) It has the individual's consent under this act and the collection, use, or disclosure, as the case may be, to the best of the custodian's knowledge, is necessary for a lawful purpose; or

The logic applied just as much to administrative proceedings: «Holding parties who receive the Record under an implied obligation not to use information in it for a collateral purpose promotes the public interest in obtaining full disclosure of [relevant] material..., just as this promise of confidentiality supports the obligation of complete disclosure between parties in civil actions» (at para. 37).

IRS Circular 230 disclosure: To ensure compliance with requirements imposed by the IRS, any tax information contained in this site was not intended or written to be used, and can not be used, for the purpose of (i) avoiding tax - related penalties under federal, state or local tax law or (ii) promoting, marketing or recommending to another party any transaction or matter addressed on this site.

Now, the Office of the Privacy Commissioner of Canada recently found that in order to properly rely on the s. 7 (3)(h. 2) exemption it is essential that an organization document the purpose for which personal information is disclosed and exercise due diligence to ensure that the disclosure is reasonable under the circumstances.

For example, a covered health care provider that had a treatment relationship with an individual prior to the individual's enrollment in a clinical trial, but that is now providing research - related treatment to the individual, may elect to request a compound authorization from the individual: an authorization under § 164.508 (d) for the provider to use the protected health information it created prior to the initiation of the research that involves treatment, combined with an authorization under § 164.508 (f) regarding use and disclosure of protected health information the covered provider will create for the purpose of the clinical trial.

In addition, we slightly modify the second of the three conditions under which covered entities may respond to such requests, to allow disclosure if the request is specific and is limited in scope to the extent reasonably practicable in light of the purpose for which the information is sought.

We recognize that covered entities sometimes make these types of uses and disclosures for purposes that are permitted under the rule without authorization.

We reviewed the important purposes for which some commenters said government agencies needed protected health information, and we believe that most of those needs can be met through the other categories of permitted uses and disclosures without authorization allowed under the final rule, including provisions permitting covered entities to disclose information (subject to certain limitations) to government agencies for public health, health oversight, law enforcement, and otherwise as required by law.

We note that a covered health care provider must obtain an authorization under § 164.508 in order to disclose protected health information about an individual for purposes of pre-enrollment underwriting; the underwriting is not an «operation» of the provider and that disclosure is not otherwise permitted by a provision of this rule.

As with any other use or disclosure, however, uses and disclosures of protected health information for these purposes do require authorization if they are not otherwise permitted under the rule.

For multiple disclosures to the same recipient pursuant to a single authorization or for a single purpose permitted under the rule without authorization, the covered entity may provide a summary accounting addressing the series of disclosures rather than a detailed accounting of each disclosure in the series.

Rather, as described above, the final rule carves out certain activities which must always be considered law enforcement for purposes of disclosure of protected health information under this rule.

For example, if under § 164.512 (b), a covered entity discloses the same protected health information to a public health authority for the same purpose every month, it can account for those disclosures by including in the accounting the date of the first disclosure, the public health authority to whom the disclosures were made and the public health authority's address, a brief description of the information disclosed, a brief description of the purpose of the disclosures, the fact that the disclosures were made every month during the accounting period, and the date of the most recent disclosure.

If the covered hospital wishes at some point in the future to make discretionary disclosures for public health purposes, it must revise its notice to so state, and Start Printed Page 82551must segregate its records so that protected health information created or received under the prior notice is not disclosed for discretionary public health purposes.

(3) If, during the period covered by the accounting, the covered entity has made multiple disclosures of protected health information to the same person or entity for a single purpose under § § 164.502 (a)(2)(ii) or 164.512, or pursuant to a single authorization under § 164.508, the accounting may, with respect to such multiple disclosures, provide:

Specifically, this overlap occurred because: (1) The NPRM preamble, but not the NPRM regulation text, indicated that agencies conducting both oversight and law enforcement activities would be subject to the oversight requirements when conducting oversight activities; and (2) the NPRM addressed some disclosures for investigations of health care fraud in the law enforcement paragraph (proposed § 164.510 (f)(5)(i)-RRB-, while health care fraud investigations are central to the purpose of health care oversight agencies (covered under proposed § 164.510 (c)-RRB-.

The disclosures permitted under § 164.512 are for national priority purposes, and determining whether a disclosure fits within the section is necessary before the disclosure can be Start Printed Page 82742made.

The exceptions to the definition of marketing fall within the definitions of treatment and / or health care operations, and therefore uses, or disclosures to a business associate, of protected health information for these purposes are permissible under the rule without authorization.

The final rule creates a narrower exemption for Department of State for uses and disclosures of protected health information (1) for purposes of a required security clearance conducted pursuant to Executive Orders 10450 and 12698; (2) as necessary to meet the requirements of determining worldwide availability or availability for mandatory service abroad under Sections 101 (a)(4) and 504 of the Foreign Service Act; and (3) for a family member to accompany a Foreign Service Officer abroad, consistent with Section 101 (b)(5) and 904 of the Foreign Service Act.

In lieu of the statement of purpose, a covered entity may include a copy of the individual's authorization under § 164.508 or a copy of a written request for disclosure, if any, under § 164.502 (a)(2)(ii) or § 164.512.

A covered entity may use and disclose the protected health information of individuals who are foreign military personnel to their appropriate foreign military authority for the same purposes for which uses and disclosures are permitted for Armed Forces personnel under the notice published in the Federal Register pursuant to paragraph (k)(1)(i) of this section.

Under the NPRM, the proposed definitions of law enforcement and oversight, and the rules governing disclosures for these purposes Start Printed Page 82529overlapped.

Disclosures for research purposes under the final rule, as in the proposed regulation, are permissive discloDisclosures for research purposes under the final rule, as in the proposed regulation, are permissive disclosuresdisclosures only.

We do not interpret the definition of «payment» to include activities that involve the disclosure of protected health information by a covered entity, including a covered health care provider, to a plan sponsor for the purpose of obtaining payment under a group health plan maintained by such plan sponsor, or for the purpose of obtaining payment from a health insurance issuer or HMO with respect to a group health plan maintained by such plan sponsor, unless the plan sponsor is performing plan administration pursuant to § 164.504 (f).

For purposes of this regulation, this means that, except for uses and disclosures for research purposes (see § 164.512 (i)-RRB-, covered entities must under this rule protect the protected health information about a deceased individual in the same manner and to the same extent as required for the protected health information of living individuals.

We also clarify the conditions under which authorization is or is not required for uses and disclosures of protected health information for marketing purposes.

Similarly, disclosure of such medical information by the group health plan, under the limited circumstances permitted by this privacy regulation, may involve use of the information for insurance purposes as broadly described in the ADA discussion above.

In general, under the final rule, to disclose or use protected health information for these purposes, covered entities must inform individuals in advance and must provide a meaningful opportunity for the individual to prevent or restrict the disclosure.

This is not the function of the disclosure obligations of developers under the statute, nor is such a result required to serve the statutory purposes underlying disclosure obligations: Sharbern SCC at para. 118.

62 The answer to the second question should therefore be that Article 9 of the directive is to be interpreted as meaning that the activities referred to at points (a) to (d) of the first question, relating to data from documents which are in the public domain under national legislation, must be considered as activities involving the processing of personal data carried out «solely for journalistic purposes», within the meaning of that provision, if the sole object of those activities is the disclosure to the public of information, opinions or ideas.

If you are an individual on whom a HireRight client has requested a background screening investigation, and have submitted personal information to HireRight at the request of such client for purposes of procuring a background report, then you can review your HireRight file in accordance with your file disclosure rights under the Fair Credit Reporting Act, California Civil Code Section 1786.22 and any other applicable state laws by contacting HireRight's Customer Service Department at [email protected].

If you are an individual on whom a SmartStart client has requested a background screening investigation, and have submitted personal information to SmartStart at the request of such client for purposes of procuring a background report, then you can review your SmartStart file in accordance with your file disclosure rights under the Fair Credit Reporting Act, California Civil Code Section 1786.22 and any other applicable state laws by contacting SmartStart's Customer Service Department at [email protected].

Under Virginia law, a minor is deemed an adult for the purpose of consenting to, and for accessing or authorizing the disclosure of medical records related to:

IRS CIRCULAR 230 DISCLOSURE To ensure compliance with requirements by the IRS, we inform you that any U.S. tax advice contained in this communication (including any attachments) is not intended or written to be used, and can not be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein.

This is also the stated purpose of the integrated disclosure under RESPA section 4 (a).